Trials / Active Not Recruiting
Active Not RecruitingNCT05360615
The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 147 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Effects of Empagliflozin compared with placebo in post severe acute kidney injury survivors, evaluated by MAKE365.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Empagliflozin 10 MG | SGLT2 inhibitors |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2024-06-01
- Completion
- 2026-07-01
- First posted
- 2022-05-04
- Last updated
- 2025-08-17
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05360615. Inclusion in this directory is not an endorsement.